Join Redox Medicine 2024
It is a great pleasure to announce the 26th International Conference on Redox Medicine 2024, which will be held on June 27-28, at Fondation Biermans-Lapôtre, Paris, France.
Speakers of Redox Medicine 2024
|
Small Molecule Electrophiles: Lessons from a Journey along the Redox Chemistry of Nitrogen Oxides to Drug Development Bruce Freeman, University of Pittsburgh, USA |
Keynote Day 2 Redox Interactome in Physiopathology Miria Ricchetti, Institut Pasteur, France |
 Antioxidants Stimulate Blood Flow in Tumors Martin O. Bergo, Karolinska Institutet, Sweden |
 Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox SignalingMario D. Cordero, Universidad Pablo de Olavide, Spain |
 Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral DementiaChristel Marquette, Laboratoire Biosanté U1292 INSERM-CEA-UGA, Equipe MAB2, France |
 Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent mannerZaher El Beck, Karolinska Institutet and Uppsala University, Sweden |
|
Tamara Tomin, TU Wien, Austria |
 The Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism NexusLaurent Chatre, ISTCT, CNRS, Université de Caen Normandie, France |
 NADH: The Redox Sensor in Aging-Related DisordersRoberta Rizzo, Università degli Studi di Ferrara, Italy |
 Redox Implications of Supplementary Oxygen during Major Abdominal SurgeryAndrew Cumpstey, University of Southampton, United Kingdom |
 New Insights into the Impact of Oxidative Stress in Hypertensive Diseases of PregnancyDaniel Vaiman, DR1 INSERM, Institut Cochin, France |
 Redox Medicine 2024: BiomarkersCarole Nicco, President of Redox Medicine Society |
 Identifying Oxidized Lipids in Neurodegenerative DiseasesSayuri Miyamoto, University of São Paulo, Brazil |
 Exploring Predictors of HDL Oxidative Stress Functionality in Post-Covid Disease and Relation to SeverityJumana Saleh, Sultan Qaboos University, Oman |
 Redox, Radiotherapy and BiomarkersRadia Tamarat, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France |
 Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative DiseasesJeffrey A. Johnson, University of Wisconsin, USA |
 Antioxidant and Prooxidant Nanozymes: From Cellular Redox Regulation to Next-Generation TherapeuticsGovindasamy Mugesh, Indian Institute of Science, India |
|
George M. Spyrou, The Cyprus Institute of Neurology & Genetics, Cyprus |
|
Duncan Emerton, Vice-President of Citeline, United Kingdom |
 How to Develop a Drug – From Preclinical to ClinicalAntonio Vila-Coro, IQVIA, Spain |
 Artificial Intelligence in NeuroInflammation, Biomarkers and Redox MedicineStéphane Mouchabac, CHU St Antoine DMU Neurosciences and Institut du Cerveau, Paris |
 Artificial Intelligence & Algorithms: Applications in Redox Medicine & RadiologyMaxime Barat, Université Paris Cité, Hôpital Cochin, France |
Redox Medicine 2024 Attendees
|
Citeline (Sponsor) |
Pusan National University |
Last updated on 12/04/2024
